Amy C. Peterson

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Camana Bay, Grand Cayman, Cayman Islands
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nina Ayer, Attorney in Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Amy C. Peterson

Form 4 holding EVP Prod Dev & Med Aff & CMO

EXELIXIS, INC.

Security class
Common Stock
Shares / value
465,393
Estimated value
$21,161,419
Report date
16 May 2025
Price
$45.47
Ownership
Direct
Form 4 holding EVP, Chief Development Officer

CytomX Therapeutics, Inc.

Security class
Common Stock
Shares / value
58,433
Estimated value
$80,678
Report date
16 Mar 2023
Price
$1.38
Ownership
Direct
Form 4 holding EVP Prod Dev & Med Aff & CMO

EXELIXIS, INC.

Security class
Option (right to buy)
Shares / value
120,000
Estimated value
Report date
16 May 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Amy C. Peterson

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .